Information Centre
born of feeling

Good news | Datacraft has been successfully identified as the 2023 Nanjing Engineering Technology Research Center

Views: 0     Author: Datafei Medical     Publish Time: 2023-06-08      Origin: Site

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
sharethis sharing button

Recently, the Nanjing Municipal Science and Technology Bureau announced the list of recognized Nanjing Engineering Technology Research Centers for 2023.After recommendation by the district-level competent authorities, expert review, deliberation at the director’s office meeting, and public announcement, etc.Built by Difei Medical Technology (Nanjing) Co., Ltd.'Nanjing Infection Metagenomic Engineering Technology Research Center'Happily recognized!

WeChat picture_20230608153019

Nanjing Engineering Technology Research CenterIt is one of the main contents of Nanjing's science and technology infrastructure construction and an important part of building a regional science and technology innovation system.By relying on the strong internal R&D institutions of enterprises to carry out technical engineering research, intermediate tests and complete sets of technical services, cultivate a high-level engineering technology R&D team, enhance the company's technological innovation, achievement transformation and industry service capabilities, and enhance Nanjing's industrial technological innovation capabilities and market competitiveness.

1Difei-Nanjing was established (1)

Founded in 2018, Difei Medical has a multi-disciplinary R&D and commercial operation team composed of hundreds of people from top domestic and foreign top universities.Difei Medical focuses on the field of molecular diagnosis of infectious etiology, has innovative automated testing processes, insists on promoting the development of multiple technology platforms, enriches product lines that better meet clinical needs, continuously improves testing quality, and serves the majority of patients.Products include tNGS-Mycobacterium tuberculosis and drug resistance gene detection TBr.16, PCR-Dixunkang series, tNGS-Dimikang series, mNGS-Digankang series, etc.

Difei Medical focuses on R&D and innovation and is committed to building infectious microorganism detection technology based on metagenomic sequencing technology, which is very consistent with the current development needs of the world's health industry.

The establishment of the 'Nanjing Infection Metagenomic Engineering Technology Research Center' project will focus on the research and development and industrialization of metagenomic sequencing respiratory infection microbial detection technology to meet the needs of the development of the precision medicine industry.The project will continue to enhance its leading and driving role in the development of the industry, steadily narrow the gap between domestic and foreign countries, comprehensively enhance the technical content and core competitiveness of my country's medical industry, and contribute to China's health industry in the coming microbiome era.

About Dinfectome

Telephone: + 86 - 4006362325
Address: No.128 Huakang Road, Jiangbei New District, Nanjing, Jiangsu Province, China
Leave a Message

Follow Us

Copyright© 2023 Difei Medical Technology (Nanjing) Co., Ltd. Su ICP No. 20046744-2 All rights reserved | Sitemap | Privacy Policy | Leadong support